Interestingly, this T-cell dysfunction was observed months after the initiation of the Leishmaniasis treatment, despite the increase of costimulatory molecules after SLA stimulation, and it resulted in low IFN-γ in CD8+ and CD4+ and granzyme B on CD8+. The gene discussed is GZMB; the disease is leishmaniasis.